Next Article in Journal / Special Issue
Conditionally Active, pH-Sensitive Immunoregulatory Antibodies Targeting VISTA and CTLA-4 Lead an Emerging Class of Cancer Therapeutics
Previous Article in Journal
Exploring Parametric and Mechanistic Differences between Expi293FTM and ExpiCHO-STM Cells for Transient Antibody Production Optimization
Previous Article in Special Issue
Suppression of MUC1-Overexpressing Tumors by a Novel MUC1/CD3 Bispecific Antibody
 
 
Article

Article Versions Notes

Antibodies 2023, 12(3), 54; https://doi.org/10.3390/antib12030054
Action Date Notes Link
article xml file uploaded 22 August 2023 07:54 CEST Original file -
article xml uploaded. 22 August 2023 07:54 CEST Update https://www.mdpi.com/2073-4468/12/3/54/xml
article pdf uploaded. 22 August 2023 07:54 CEST Version of Record https://www.mdpi.com/2073-4468/12/3/54/pdf
article supplementary file uploaded. 22 August 2023 07:54 CEST - https://www.mdpi.com/2073-4468/12/3/54#supplementary
article html file updated 22 August 2023 07:56 CEST Original file https://www.mdpi.com/2073-4468/12/3/54/html
Back to TopTop